ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
BCII Enterprises Inc (PK)

BCII Enterprises Inc (PK) (BCII)

0,0195
0,0015
(8,33%)
Geschlossen 06 Januar 10:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,0195
Gebot
0,016
Fragen
0,0282
Volumen
7.472
0,018 Tagesbereich 0,0195
0,01025 52-Wochen-Bereich 0,0399
Marktkapitalisierung
Handelsende
0,018
Handelsbeginn
0,018
Letzte Trade
5222
@
0.0195
Letzter Handelszeitpunkt
Finanzvolumen
US$ 143
VWAP
0,019182
Durchschnittliches Volumen (3 Mio.)
186.553
Ausgegebene Aktien
47.196.686
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,26
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-177k

Über BCII Enterprises Inc (PK)

The Company, referred to as BCII, was formerly a shell. On December 15, 2021, BCIi completed the acquisition of 100% of the capital stock of NFT Clearing, Inc. pursuant to a Share Exchange Agreement. Additionally, on or about July 17, 2022, BCII purchased 100% of the capital stock of YourInfo.com Co... The Company, referred to as BCII, was formerly a shell. On December 15, 2021, BCIi completed the acquisition of 100% of the capital stock of NFT Clearing, Inc. pursuant to a Share Exchange Agreement. Additionally, on or about July 17, 2022, BCII purchased 100% of the capital stock of YourInfo.com Corp. In connection with its acquisitions of NFT Clearing on December 15, 2021, and YourInfo on July 17, 2022, and that during the period from January 2022 through October 2022, BCII received advances of approximately $520,000 to fund BCII's operations and that of its subsidiaries, including hiring consultants to provide bona fide services and since March 2022 received investments evidenced by software technology designed to enable users to download all the information that any website gathers on them such as Facebook, Google and Amazon, which was previously difficult to access, BCII ceased being a shell company and became a non-shell company effective on August 1, 2022.. YourInfo translates the information for individual users providing the technology they need to gather their data from Web 2.0 sites so that they can market that data for themselves, so as to act as the unique bridge to Web 3.0, NFT Clearing has teamed up with a regulated NFT exchange to allow the trading of the individual's unique key that advertisers will use to view the aforementioned data, which key will be auctioned off on the regulated NFT exchange. Mehr anzeigen

Sektor
Business Services, Nec
Branche
Business Services, Nec
Hauptsitz
Lewes, Delaware, USA
Gegründet
-
BCII Enterprises Inc (PK) is listed in the Business Services sector of the OTCMarkets with ticker BCII. The last closing price for BCII Enterprises (PK) was US$0,02. Over the last year, BCII Enterprises (PK) shares have traded in a share price range of US$ 0,01025 to US$ 0,0399.

BCII Enterprises (PK) currently has 47.196.686 shares in issue. The market capitalisation of BCII Enterprises (PK) is US$849.540,35 . BCII Enterprises (PK) has a price to earnings ratio (PE ratio) of -5.26.

BCII Neueste Nachrichten

ImmuDyne Announces Strategic Blockchain-Linked Investment

NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader in the development and online marketing of OTC health and wellness products...

Genzyme, Bone Care International Announce Shareholder Approval of Merger

Genzyme, Bone Care International Announce Shareholder Approval of Merger Acquisition to Strengthen Genzyme's Growing Renal Business CAMBRIDGE, Mass. and MIDDLETON, Wis., June 30...

Genzyme and Bone Care International Announce Completion of Hart-Scott-Rodino Review

Genzyme and Bone Care International Announce Completion of Hart-Scott-Rodino Review CAMBRIDGE, Mass. and MADISON, Wis., June 15 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and...

Bone Care International Announces Patent Issuance

Bone Care International Announces Patent Issuance Patent for Stabilized Hydroxyvitamin D2 Products Covers Hectorol(R) (doxercalciferol) MIDDLETON, Wis., June 7 /PRNewswire-FirstCall/ -- Bone...

Medicare Part D Coverage to Include D-Hormones

Medicare Part D Coverage to Include D-Hormones MIDDLETON, Wis., May 18 /PRNewswire-FirstCall/ -- Bone Care International, Inc. (NASDAQ:BCII) announces that the Centers for Medicare and...

Bone Care International Announces Advancement of LR-103 Into Human Patients With Stage 5 Chronic Kidney Disease

Bone Care International Announces Advancement of LR-103 Into Human Patients With Stage 5 Chronic Kidney Disease - New Vitamin D Hormone Replacement Therapy for Chronic Kidney Disease...

Genzyme and Bone Care International Announce Merger Agreement ------------------------------------------------------ Genzyme to

Genzyme and Bone Care International Announce Merger Agreement Genzyme to Acquire Bone Care, Adding Complementary Therapy to Renagel; Accelerates Commercial Entry into Earlier Stages of Chronic...

Bone Care International, Inc. Reports Third Quarter FY 2005 Financial Results

Bone Care International, Inc. Reports Third Quarter FY 2005 Financial Results - Quarterly Hectorol(R) Sales of $22.0 Million, 89% Increase - MIDDLETON, Wis., April 26 /PRNewswire-FirstCall/...

Bone Care International Names Charles W. Bishop, Ph.D., as Executive Vice President and Chief Scientific Officer

Bone Care International Names Charles W. Bishop, Ph.D., as Executive Vice President and Chief Scientific Officer MIDDLETON, Wis., April 25 /PRNewswire-FirstCall/ -- Bone Care International, Inc...

Bone Care International to Present at Deutsche Bank Health Care Conference

Bone Care International to Present at Deutsche Bank Health Care Conference MIDDLETON, Wis., April 22 /PRNewswire-FirstCall/ -- Bone Care International, Inc. (NASDAQ:BCII) today announced that...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.00075-3.70370370370.020250.0290.016951020.01873879CS
4-0.0095-32.75862068970.0290.03690.016966840.02323388CS
120.00158.333333333330.0180.03690.010251865530.01684763CS
260.007560.01250.03690.010251229480.01859969CS
52-0.001855-8.686490283310.0213550.03990.01025853850.01938847CS
156-0.1555-88.85714285710.1750.30.01025526550.05629354CS
260-0.9905-98.06930693071.0190.01025792470.37999961CS

BCII - Frequently Asked Questions (FAQ)

What is the current BCII Enterprises (PK) share price?
The current share price of BCII Enterprises (PK) is US$ 0,0195
How many BCII Enterprises (PK) shares are in issue?
BCII Enterprises (PK) has 47.196.686 shares in issue
What is the market cap of BCII Enterprises (PK)?
The market capitalisation of BCII Enterprises (PK) is USD 849,54k
What is the 1 year trading range for BCII Enterprises (PK) share price?
BCII Enterprises (PK) has traded in the range of US$ 0,01025 to US$ 0,0399 during the past year
What is the PE ratio of BCII Enterprises (PK)?
The price to earnings ratio of BCII Enterprises (PK) is -5,26
What is the reporting currency for BCII Enterprises (PK)?
BCII Enterprises (PK) reports financial results in USD
What is the latest annual profit for BCII Enterprises (PK)?
The latest annual profit of BCII Enterprises (PK) is USD -177k
What is the registered address of BCII Enterprises (PK)?
The registered address for BCII Enterprises (PK) is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the BCII Enterprises (PK) website address?
The website address for BCII Enterprises (PK) is www.bciienterprises.com
Which industry sector does BCII Enterprises (PK) operate in?
BCII Enterprises (PK) operates in the BUSINESS SERVICES, NEC sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EGIOQEdgio Inc (CE)
US$ 0,01
(999.900,00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799.900,00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0,001
(99.900,00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796,08
(26.436,00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0,0002
(19.900,00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0,000001
(-99,98%)
102,53k
VICFFVice Health and Wellness Inc (CE)
US$ 0,000001
(-99,97%)
996
SAFSSafer Shot Inc (CE)
US$ 0,000001
(-99,93%)
2,54M
ERFBERF Wireless Inc (CE)
US$ 0,0001
(-99,89%)
99,77k
ARVLFArrival (CE)
US$ 0,0002
(-99,60%)
42,86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0038
(52,00%)
608,97M
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
546,25M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
501,07M
CBIACanopus Biopharma Inc (PK)
US$ 0,0002
(100,00%)
281,95M
RDARRaadr Inc (PK)
US$ 0,00125
(-10,71%)
169,44M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen